Fresenius SE & Co. KGaA (ETR:FRE)
Germany
· Delayed Price · Currency is EUR 42.59
+0.40 (0.95%)
Jun 27, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Fresenius Kabi | 8.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Kabi Growth | 5.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Helios | 12.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Helios Growth | 7.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Medical Care | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Medical Care Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate | 386.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Growth | 13.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg1 | 233.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg1 Growth | -62.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
North America | 2.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 3.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 15.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 6.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia-Pacific | 1.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia-Pacific Growth | 0.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America | 1.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America Growth | 16.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | 159.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | 14.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Fresenius Kabi Operating Income | 1.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Kabi Operating Income Growth | 16.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Helios Operating Income | 1.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Helios Operating Income Growth | -4.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Medical Care Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Medical Care Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Operating Income | -130.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Operating Income Growth | 44.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Hospitals | 85.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Hospitals Growth | 0% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Beds | 29.81K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Beds Growth | -0.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Hospital Patients | 1.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Hospital Patients Growth | 1.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Outpatient Patients | 4.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Germany - Number of Outpatient Patients Growth | 2.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed - Order Intake | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed - Order Intake Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed - Order Backlog | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fresenius Vamed - Order Backlog Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Organic Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Hospitals | 57.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Hospitals Growth | -1.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Beds | 8.11K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Beds Growth | -2.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Hospital Patients | 1.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Hospital Patients Growth | 1.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Outpatient Patients | 19.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Helios Spain - Number of Outpatient Patients Growth | 1.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|